These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30604176)

  • 1. Topical Delivery of Artemisone, Clofazimine and Decoquinate Encapsulated in Vesicles and Their In vitro Efficacy Against Mycobacterium tuberculosis.
    van Zyl L; Viljoen JM; Haynes RK; Aucamp M; Ngwane AH; du Plessis J
    AAPS PharmSciTech; 2019 Jan; 20(1):33. PubMed ID: 30604176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation of Natural Oil Nano-Emulsions for the Topical Delivery of Clofazimine, Artemisone and Decoquinate.
    Burger C; Aucamp M; du Preez J; Haynes RK; Ngwane A; du Plessis J; Gerber M
    Pharm Res; 2018 Aug; 35(10):186. PubMed ID: 30088097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of the simultaneous determination of artemisone, clofazimine and decoquinate with HPLC.
    Preez JLD; Aucamp ME; Burger C; Gerber M; Viljoen JM; Zyl LV; Plessis JD
    Pharmazie; 2018 Mar; 73(3):139-142. PubMed ID: 29544560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro skin permeation of artemisone and its nano-vesicular formulations.
    Dwivedi A; Mazumder A; Fox LT; Brümmer A; Gerber M; du Preez JL; Haynes RK; du Plessis J
    Int J Pharm; 2016 Apr; 503(1-2):1-7. PubMed ID: 26930566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery.
    Balakrishnan P; Shanmugam S; Lee WS; Lee WM; Kim JO; Oh DH; Kim DD; Kim JS; Yoo BK; Choi HG; Woo JS; Yong CS
    Int J Pharm; 2009 Jul; 377(1-2):1-8. PubMed ID: 19394413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical delivery of roxithromycin solid-state forms entrapped in vesicles.
    Csongradi C; du Plessis J; Aucamp ME; Gerber M
    Eur J Pharm Biopharm; 2017 May; 114():96-107. PubMed ID: 28119103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of novel diolein-niosomes for cutaneous delivery of tretinoin: influence of formulation and in vitro assessment.
    Manca ML; Manconi M; Nacher A; Carbone C; Valenti D; Maccioni AM; Sinico C; Fadda AM
    Int J Pharm; 2014 Dec; 477(1-2):176-86. PubMed ID: 25455770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-invasive vaccine delivery in transfersomes, niosomes and liposomes: a comparative study.
    Gupta PN; Mishra V; Rawat A; Dubey P; Mahor S; Jain S; Chatterji DP; Vyas SP
    Int J Pharm; 2005 Apr; 293(1-2):73-82. PubMed ID: 15778046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clofazimine encapsulation in nanoporous silica particles for the oral treatment of antibiotic-resistant Mycobacterium tuberculosis infections.
    Valetti S; Xia X; Costa-Gouveia J; Brodin P; Bernet-Camard MF; Andersson M; Feiler A
    Nanomedicine (Lond); 2017 Apr; 12(8):831-844. PubMed ID: 28338408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo evaluation of Bola-surfactant containing niosomes for transdermal delivery.
    Paolino D; Muzzalupo R; Ricciardi A; Celia C; Picci N; Fresta M
    Biomed Microdevices; 2007 Aug; 9(4):421-33. PubMed ID: 17252206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and optimization of lacidipine loaded niosomal gel for transdermal delivery: In-vitro characterization and in-vivo activity.
    Qumbar M; Ameeduzzafar ; Imam SS; Ali J; Ahmad J; Ali A
    Biomed Pharmacother; 2017 Sep; 93():255-266. PubMed ID: 28738502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of follicular delivery of finasteride by liposomes and niosomes 1. In vitro permeation and in vivo deposition studies using hamster flank and ear models.
    Tabbakhian M; Tavakoli N; Jaafari MR; Daneshamouz S
    Int J Pharm; 2006 Oct; 323(1-2):1-10. PubMed ID: 16837150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clofazimine in the treatment of multidrug-resistant tuberculosis.
    Xu HB; Jiang RH; Xiao HP
    Clin Microbiol Infect; 2012 Nov; 18(11):1104-10. PubMed ID: 22192631
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Knoll KE; van der Walt MM; Loots DT
    Microbiol Spectr; 2022 Apr; 10(2):e0231521. PubMed ID: 35352998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A topical dosage form of liposomal clofazimine: research and clinical implications.
    Patel VB; Misra AN; Marfatia YS
    Pharmazie; 1999 Jun; 54(6):448-51. PubMed ID: 10399190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of 8-methoxypsoralen topical delivery via nanosized niosomal vesicles: Formulation development, in vitro and in vivo evaluation of skin deposition.
    Kassem AA; Abd El-Alim SH; Asfour MH
    Int J Pharm; 2017 Jan; 517(1-2):256-268. PubMed ID: 27956194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and characterization of oleic acid vesicles for the topical delivery of fluconazole.
    Zakir F; Vaidya B; Goyal AK; Malik B; Vyas SP
    Drug Deliv; 2010 May; 17(4):238-48. PubMed ID: 20235758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation of Niosomal Gel for Enhanced Transdermal Lornoxicam Delivery: In-Vitro and In-Vivo Evaluation.
    El-Ridy MS; Yehia SA; Mohsen AM; El-Awdan SA; Darwish AB
    Curr Drug Deliv; 2018; 15(1):122-133. PubMed ID: 28240177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicochemical properties and skin permeation of Span 60/Tween 60 niosomes of ellagic acid.
    Junyaprasert VB; Singhsa P; Suksiriworapong J; Chantasart D
    Int J Pharm; 2012 Feb; 423(2):303-11. PubMed ID: 22155414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection of high efficient transdermal lipid vesicle for curcumin skin delivery.
    Zhao YZ; Lu CT; Zhang Y; Xiao J; Zhao YP; Tian JL; Xu YY; Feng ZG; Xu CY
    Int J Pharm; 2013 Sep; 454(1):302-9. PubMed ID: 23830940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.